In October 2024, Novartis announced that based on its review of 48-week data from the Phase 3 MANIFEST-2 study, longer follow-up time is needed to determine the regulatory path for pelabresib in ...

Mattel continues to harvest gains from its turnaround, delivering above breakeven operating margins starting in 2019 and reaching 13.7% in 2024. Despite the outlook for modestly positive sales growth, ...

With approximately 95% of its revenue from the defense sector, Saab is well positioned to capitalize on the expected increase in European defense budgets to at least 2% of GDP due to the ...

On February 6, 2025, the SEC announced that it was providing a temporary exemption from compliance with Rule 13f-2 under the ...

InMode benefits from the booming non-invasive plastic surgery market, expected to grow at a 14% CAGR from 2023 to 2030. Read ...

Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world's leading provider of digital manufacturing services, today announced financial results for the ...

Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues ...

Net sales from our most important Hong Kong business up sequentially and year-over-year during the 4th quarter– Positive cash flows from ...